Old and new calcimimetics for treatment of secondary hyperparathyroidism: Impact on biochemical and relevant clinical outcomes

Secondary hyperparathyroidism (SHPT) is associated with increased bone turnover, risk of fractures, vascular calcifications, and cardiovascular and all-cause mortality. The classical treatment for SHPT includes active vitamin D compounds and phosphate binders. However, achieving the optimal laborato...

Full description

Bibliographic Details
Main Author: Pereira, L (author)
Other Authors: Meng, C (author), Marques, D (author), Frazão, JM (author)
Format: article
Language:eng
Published: 2018
Subjects:
Calcimimetic agents
Chronic kidney disease
Cinacalcet
Etelcalcetide
Secondary hyperparathyroidism
Online Access:https://hdl.handle.net/10216/126485
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/126485

Internet

https://hdl.handle.net/10216/126485

Similar Items